References
- de Hoog G, Guarro J, Tan CS, Wintermans RGF, Gene J. Hyphomycetes. de Hoog GS, Guarro J. Atlas of Clinical Fungi. Reus, España and Utrecht, The Netherlands: Universitat Rovira i Virgili and Centraalbureau voor Schimmelcultures, 1995; 380–1007.
- Holden DW. DNA mini prep method for Aspergillus fumigatus (and other filamentous fungi). Molecular Biology of Pathogenic Fungi, a Laboratory ManualMaresca B, Kobayashi GS, . New York: Telos Press, 1994; 3–4.
- National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: Approved Standard Document M38-A. 2002.
- Aberkane A, Cuenca-Estrella M, Gomez-Lopez A, . Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. J Antimicrob Chemother 2002; 50: 719–722.
- Petrikkou E, Rodriguez-Tudela JL, Cuenca-Estrella M, . Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans. J Clin Microbiol 2001; 39: 1345–1347.
- Rodriguez-Tudela JL, Chryssanthou E, Petrikkou E, . Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi. J Clin Microbiol 2003; 41: 5236–5237.
- Arikan S, Lozano-Chiu M, Paetznick V, Rex JH. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother 2001; 45: 327–330.
- Kurtz MB, Heath IB, Marrinan J, . Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase. Antimicrob Agents Chemother 1994; 38: 1480–1489.
- Guarro J, Nucci M, Akiti T, . Phialemonium fungemia: two documented nosocomial cases. J Clin Microbiol 1999; 37: 2493–2497.
- Proia LA, Hayden MK, Kammeyer PL, . Phialemonium: an emerging mold pathogen that caused 4 cases of hemodialysis-associated endovascular infection. Clin Infect Dis 2004; 39: 373–379.
- Strahilevitz J, Rahav G, Schroers HJ, . An outbreak of Phialemonium infective endocarditis linked to intracavernous penile injections for the treatment of impotence. Clin Infect Dis 2005; 40: 781–786.
- Weinberger M, Mahrshak I, Keller N, . Isolated endogenous endophthalmitis due to a sporodochial-forming Phialemonium curvatum acquired through intracavernous autoinjections. Med Mycol 2006; 44: 253–259.
- Gams W, McGinnis MR. Phialemonium, a new anamorph genus intermediate between Phialophora and Acremonium. Mycologia 1983; 75: 977–987.
- McGinnis MR, Gams W, Goodwin MN, Jr. Phialemonium obovatum infection in a burned child. J Med Vet Mycol 1986; 24: 51–55.
- Dixon DM, Polak-Wyss A. The medically important dematiaceous fungi and their identification. Mycoses 1991; 34: 1–18.
- Dan M, Yossepowitch O, Hendel D, Shwartz O, Sutton DA. Phialemonium curvatum arthritis of the knee following intra-articular injection of a corticosteroid. Med Mycol 2006; 44: 571–574.
- Gavin PJ, Sutton DA, Katz BZ. Fatal endocarditis in a neonate caused by the dematiaceous fungus Phialemonium obovatum: case report and review of the literature. J Clin Microbiol 2002; 40: 2207–2212.
- Heins-Vaccari EM, Machado CM, Saboya RS, . Phialemonium curvatum infection after bone marrow transplantation. Rev Inst Med Trop Sao Paulo 2001; 43: 163–166.
- King D, Pasarell L, Dixon DM, McGinnis MR, Merz WG. A phaeohyphomycotic cyst and peritonitis caused by Phialemonium species and a reevaluation of its taxonomy. J Clin Microbiol 1993; 31: 1804–1810.
- Silveira F, Nucci M. Emergence of black moulds in fungal disease: epidemiology and therapy. Curr Opin Infect Dis 2001; 14: 679–684.
- Brandt ME, Warnock DW. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother 2003; 15Suppl. 2:36–47.
- Revankar SG. Dematiaceous fungi. Mycoses 2007; 50: 91–101.
- Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 2002; 34: 467–476.
- Guarro J, Gams W, Pujol I, Gene J. Acremonium species: new emerging fungal opportunists–in vitro antifungal susceptibilities and review. Clin Infect Dis 1997; 25: 1222–1229.
- Liu K, Howell DN, Perfect JR, Schell WA. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am J Clin Pathol 1998; 109: 45–54.
- Perfect JR, Schell WA. The new fungal opportunists are coming. Clin Infect Dis 1996; 22Suppl. 2:S112–S118.
- Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 2001; 39: 954–958.
- McGinnis MR, Pasarell L. In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications. J Clin Microbiol 1998; 36: 2353–2355.
- Magnon KC, Jalbert M, Padhye AA. Osteolytic phaeohyphomycosis caused by Phialemonium obovatum. Arch Pathol Lab Med 1993; 117: 841–843.
- Schonheyder HC, Jensen HE, Gams W, . Late bioprosthetic valve endocarditis caused by Phialemonium curvatum and Streptococcus sanguis: a case report. J Med Vet Mycol 1996; 34: 209–214.
- Scott RS, Sutton DA, Jagirdar J. Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract. Ann Diagn Pathol 2005; 9: 227–230.